These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 6676775)

  • 1. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of hepatic parenchymatous function. Contribution of the galactose clearance test. Study by multidimensional statistical analysis].
    Hecht Y; Ben Amar A; Touboul JP; el-Guedry H; Salmon D; Nakache JP
    Nouv Presse Med; 1972 Dec; 1(46):3133-4. PubMed ID: 4650517
    [No Abstract]   [Full Text] [Related]  

  • 4. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The free bilirubin tolerance test as a liver function test and its comparison with the BSF tolerance test].
    Gentilini P; Surrenti C; Candidi Tommasi A; Camilloni R
    Sperimentale; 1969; 119(4):281-97. PubMed ID: 5402934
    [No Abstract]   [Full Text] [Related]  

  • 6. [Simultaneous bromsulfalein and galactose loading as a liver function test].
    Nilsson LH; Hultman E
    Nord Med; 1971 Aug; 85(31):942-3. PubMed ID: 5569721
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.
    Nilsson LH; Hultman E
    Scand J Gastroenterol; 1974; 9(3):319-23. PubMed ID: 4850181
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation of the hepatocyte.
    Tygstrup N; Vilstrup H
    Lab Res Methods Biol Med; 1983; 7():17-41. PubMed ID: 6353103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver tests and tests of liver function (author's transl)].
    Bircher J; Colombo JP
    Ther Umsch; 1978 Sep; 35(9):701-6. PubMed ID: 360471
    [No Abstract]   [Full Text] [Related]  

  • 10. Galactose retention: an alternative to the bromsulphthalein test.
    Sinniah D
    Singapore Med J; 1974 Dec; 15(4):273-5. PubMed ID: 4458070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood cholinesterase and hepatic function: a comparison with BSP and galactose elimination as well as serum albumin concentration].
    Gross O; Audetat V; Bircher J
    Schweiz Med Wochenschr; 1978 Sep; 108(36):1389-93. PubMed ID: 705294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative liver function studies with high doses of BSP in intravenous galactose loading].
    Lamberts SW; Hörchner P; Birkenhäger JC
    Tijdschr Gastroenterol; 1971; 14(3):195-204. PubMed ID: 5160356
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative assessment of deranged hepatic function: a missed opportunity?
    Bircher J
    Semin Liver Dis; 1983 Nov; 3(4):275-84. PubMed ID: 6359423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum cholylglycine in the evaluation of impaired hepatic function].
    Salmi A; Pizzoccolo G; Uccelli P; Paterlini A; Moretti R
    Minerva Med; 1986 Apr; 77(17):687-91. PubMed ID: 2872621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
    Tengström B
    Scand J Clin Lab Invest Suppl; 1966; 18():132-42. PubMed ID: 5958513
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatic clearance of sulfobromophthalein administered in small doses in subjects with hepatobiliary diseases].
    Cravario A; Molino G; Giangrandi E
    Minerva Gastroenterol; 1966; 12(4):135-41. PubMed ID: 5993623
    [No Abstract]   [Full Text] [Related]  

  • 17. [Exploration of hepato-biliary function with I-131 labeled BSF. II. Hepato-biliary dynamic scintiscanning].
    Quattrocchi G; Squillaci S; Grasso E; Arcoraci A
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):924-9. PubMed ID: 4463980
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of liver function in endemic nephropathy].
    Milev B
    Z Gesamte Inn Med; 1972 Jul; 27(14):601-5. PubMed ID: 5082874
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous galactose-tolerance test in liver cirrhosis. A comparison with bromsulfalein leading].
    Järnerot G
    Nord Med; 1970 Dec; 84(50):1586-8. PubMed ID: 5519422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.